Lpath Granted Key European and U.S. Patents Related to Anti-Cancer Drug Program, ASONEP

[Marketwired] – Lpath, Inc. , the industry leader in bioactive lipid-targeted therapeutics, received official notification from the European Patent Office and the U.S. Patent and Trademark Office that the company has … more

View todays social media effects on LPTN

View the latest stocks trending across Twitter. Click to view dashboard

See who Lpath is hiring next, click here to view